# KeyReply Pte

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/keyreply-pte

- Industry: Software
- Headquarters: Singapore, Singapore
- Website: www.keyreply.com
- Total disclosed funding: $0.2M
- Latest round: Angel (Apr 1, 2016)
- Investors on record: 1

## About

KeyReply Pte Ltd is a Singaporean company that specializes in AI-powered virtual assistant solutions, enhancing operational efficiency primarily within healthcare settings. Their innovative platform facilitates patient interactions, streamlining workflows and improving care delivery.Founded in 2014, KeyReply Pte Ltd is centered on developing AI-driven solutions for healthcare. The company, headquartered in Singapore, has raised a total of USD 1.00 mn through its Series A funding round on July 5, 2019, which values it at USD 6.00 mn post-money. The CEO is Peiru Teo, and the firm was established by Max Xu, who has a background in entrepreneurial ventures.KeyReply offers AI-powered virtual assistant solutions, prominently featuring their product, kira™, which automates patient interactions and workflows by integrating seamlessly with healthcare systems. Kira™ supports scheduling, reminders, and follow-ups, thereby reducing administrative burdens on healthcare staff. It is developed over six years using real-world healthcare data and is currently employed by leading healthcare facilities across the Asia-Pacific, Middle East, United Kingdom, and United States, aiming to enhance patient engagement and streamline operational processes.In the most recent year, KeyReply reported revenue of USD 2,119,032.50 and earnings before interest, taxes, depreciation, and amortization (EBITDA) of USD 112,002.20 for 2022. Their revenue model is subscription-based, allowing healthcare providers to access the kira™ platform for ongoing operational support and patient engagement features.KeyReply plans to enhance its offerings with new features being developed for the kira™ platform, aiming for a rollout in the coming year. Additionally, the company is targeting expansion into new markets, specifically in Europe and Southeast Asia, by 2024. The recent Series A funding of USD 1.00 mn will be utilized to bolster product development and support their entry into these regions, as they seek to capture a larger share of the healthcare technology market.

## Funding rounds

- Angel, Apr 1, 2016, $0.2M — Blue Startups
- Angel, Oct 15, 2015, $0M — Blue Startups

## Investors

- Blue Startups (https://capitalatlas.ai/funds/blue-startups) — Angel